Mazor Robotics wins FDA clearance to extend its Renaissance robotic platform into brain surgery.
The device, originally designed for spinal surgeries, is now cleared for use in positioning surgical instruments and implants during procedures on the brain, including biopsies, shunt placements and neurostimulation electrode placement for deep brain stimulation.
The Renaissance system, which Mazor unveiled in the summer of 2011 , was built on the core of the company's previous generation SpineAssist technology.
Mazor Robotics wins FDA clearance to extend its Renaissance robotic platform into brain surgery. Mazor Robotics (PINK:MZRTF) won FDA clearance extending use of its Renaissance robotic system into brain surgery, the company announced this week.